VaccineHumansMaleFemaleAgedAntibodies
Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents.
Jessica A Breznik, Jann C Ang, Hina Bhakta, Li-Min Liu, Lucas Bilaver, Allison E Kennedy, Braeden Cowbrough, Ahmad Rahim, Rumi Clare, Jonathan L Bramson, Ishac Nazy, Matthew S Miller, Andrew P Costa, Dawn M E Bowdish, COVID in Long-Term Care Study
Published: 202610.1016/j.vaccine.2025.128160
Abstract
BACKGROUND: Older adults were administered sequential heterogenous bivalent Ancestral/Omicron BA.1 and Ancestral/Omicron BA.4/5 SARS-CoV-2 mRNA vaccines in 2022-2023 in Ontario, Canada. Immunogenicity of this unique vaccination schedule was evaluated…
Preview only. Read the full abstract at the source